DSP-0390, an investigational new agent developed by Cambridge, Massachusetts-based Sumitomo Dainippon Pharma Oncology, is an inhibitor of emopamil-binding protein (EBP), a molecule in cholesterol biosynthesis. DSP-0390 has not been approved …
Topic:
treats
-
-
DeSantis said the left treats COVID-19 viral treatments like voodoo and don’t believe in the treatment
by Phil StiltonFlorida Governor Ron DeSantis said the press and the left treated COVID-19 virus treatment like voodoo and criticized the media for a double standard in covering COVID-19 outbreaks in red …